View from the Nation's Capital. Investigational new drug (IND) and new drug application (NDA)
Romansky, M.A.
Journal of Clinical Psychopharmacology 3(3): 193-194
1983
ISSN/ISBN: 0271-0749 PMID: 6680405 Document Number: 213146
Document emailed within 1 workday
Related Documents
Farber, M.S.; Garabedian-Ruffalo, S.M. 1990: Applying drug-use evaluation principles to investigational or unlabeled drug use American Journal of Hospital Pharmacy 47(3): 598-599Appler, W.D.; McMann, G.L. 1989: View from the Nation's Capital. Combating research misconduct Journal of Clinical Psychopharmacology 9(2): 137-138
Anandan, J.V.; Isopi, M.J.; Warren, A.J. 1993: Fee structure for investigational drug studies American Journal of Hospital Pharmacy 50(11): 2339-2343
Rogers, S.D.; Lampasona, V.; Buchanan, E.C. 1994: The financial impact of investigational drug services Topics in Hospital Pharmacy Management 14(1): 60-66
Iteen, S.A.; Ceppaglia, J. 1992: Investigational drug information through a hospitalwide computer system American Journal of Hospital Pharmacy 49(11): 2746-2748
Zola, E.M.; Overbach, A.M.; Gunkel, J.H.; Mitchell, B.R.; Nagle, B.T.; DeMarco, N.G.; Henwood, G.A.; Gold, A.J. 1993: Treatment Investigational new Drug experience with Survanta (beractant) Pediatrics 91(3): 546-551
Grilley, B.J.; Trissel, L.A.; Bluml, B.M. 1991: Design and implementation of an electronic investigational drug accountability system American Journal of Hospital Pharmacy 48(12): 2616-2618
Tankanow, R.M.; Savitsky, M.E.; Volger, B.W.; Ryan, M.L.; Colvin, C.L. 1989: Quality assurance program for a hospital investigational-drug service American Journal of Hospital Pharmacy 46(5): 962-969
Kutter, E.; Austel, V. 1981: Application of the theory of sets to drug design. Development of a new cardiotonic drug AR-L 115 BS Arzneimittel-Forschung 31(1a): 135-141
Furue, H. 1986: Application and problems of combination drug therapy--drug interactions of antineoplastic agents and antibiotics Nihon Rinsho. Japanese Journal of Clinical Medicine 44(4): 942-946
Andersson, M.L.; Böttiger, Y.; Lindh, J.D.; Wettermark, B.; Eiermann, B. 2013: Impact of the drug-drug interaction database SFINX on prevalence of potentially serious drug-drug interactions in primary health care European Journal of Clinical Pharmacology 69(3): 565-571
Richman, D. 1986: Drug abuse may present growth opportunity for nation's hospitals Modern Healthcare 16(21): 46-52
Ostrom, E.; Ahn, T.K. 2003: Una perspectiva del capital social desde las ciencias sociales: capital social y acción colectiva - A view of social capital from social sciences: social capital and collective action - Une perspective du capital social à partir des sciences sociales : capital social et action collective Revista Mexicana de Sociologia 65(1): 155-233
Azim, T.; Rahman, M.; Alam, M.S.; Chowdhury, I.A.; Khan, R.; Reza, M.; Rahman, M.; Chowdhury, E.I.; Hanifuddin, M.; Rahman, A.S.M.M. 2008: Bangladesh moves from being a low-prevalence nation for HIV to one with a concentrated epidemic in injecting drug users International Journal of Std and Aids 19(5): 327-331
Zubrzycki, G. 1997: De la nation ethnique à la nation civique : enjeux pour l'Eglise catholique polonaise - From the ethnic nation to the civic nation : stakes for the polish catholic Church International Conference on the Sociology of Religion 44(1): 37-51
Nishikaze, O. 1975: Drug-drug interaction and drug-induced interference with clinical laboratory test procedures--chairman's introductory remarks Rinsho Byori. Japanese Journal of Clinical Pathology 23(2): 75
Malta, M.; Bastos, F.I.; da Silva, C.M.F.P.; Pereira, G.F.M.; Lucena, F.F.A.; Fonseca, M.G.P.; Strathdee, S.A. 2009: Differential survival benefit of universal HAART access in Brazil: a nation-wide comparison of injecting drug users versus men who have sex with men Journal of Acquired Immune Deficiency Syndromes 52(5): 629-635
Blake, D.A. 1973: What is drug abuse? the view of a pharmacologist Maryland State Medical Journal 22(6): 27-28
Matsuda, T. 1993: Antithrombotic drug (thrombolytic drug, anticoagulant, antiplatelet drug) Nihon Rinsho. Japanese Journal of Clinical Medicine 51 Suppl: 179-185
Kohl, C.; Steinkellner, M. 2000: Prediction of pharmacokinetic drug/drug interactions from in vitro data: interactions of the nonsteroidal anti-inflammatory drug lornoxicam with oral anticoagulants Drug Metabolism and Disposition: the Biological Fate of Chemicals 28(2): 161-168